Cargando…
Serum Progranulin as an Independent Marker of Liver Fibrosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
Background: Elevated progranulin levels are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. Progranulin has not been previously investigated as a biomarker of nonalcoholic fatty liver disease (NAFLD). We sought to determine whether serum progranulin levels are altered in...
Autores principales: | Yilmaz, Yusuf, Eren, Fatih, Yonal, Oya, Polat, Zulfikar, Bacha, Mohammad, Kurt, Ramazan, Ozturk, Oguzhan, Avsar, Erol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826876/ https://www.ncbi.nlm.nih.gov/pubmed/22045426 http://dx.doi.org/10.3233/DMA-2011-0815 |
Ejemplares similares
-
Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease
por: Yilmaz, Yusuf, et al.
Publicado: (2011) -
Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2021) -
Gallstone Disease Does Not Predict Liver Histology in Nonalcoholic Fatty Liver Disease
por: Yilmaz, Yusuf, et al.
Publicado: (2014) -
Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease
por: Alsaif, Faisal A., et al.
Publicado: (2020) -
Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2019)